🟢 Cardio Diagnostics Holdings is trading 12.45% up in pre-market with no confirmed catalyst identified

Cardio Diagnostics Holdings is trading at $2.26 (+12.45%) in pre-market with no confirmed company-specific catalyst identified for August 14, 2026.

• The company recently announced an August 20 investor call covering tests, studies, reimbursement, and growth initiatives; the announcement predates this move.
• The broader market is only modestly mixed before the open and does not clearly explain the advance.
• Recent sharp gains may have increased speculative trading and volatility.